Marissa S Ghant1,2, Katherine S Sengoba1, Robert Vogelzang3, Angela K Lawson1, Erica E Marsh1. 1. 1 Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University , Chicago, Illinois. 2. 2 University of Illinois at Chicago College of Medicine , Chicago, Illinois. 3. 3 Department of Radiology, Feinberg School of Medicine, Northwestern University , Chicago, Illinois.
Abstract
BACKGROUND: Uterine fibroids are benign tumors that are the leading cause of hysterectomy in the United States. Despite their high prevalence and associated morbidity, there are little qualitative data characterizing what drives women's treatment-seeking behavior for their fibroids. METHODS: Women with symptomatic or recently treated uterine fibroids completed in-depth interviews and demographic surveys. Interviews were transcribed verbatim and uploaded to NVivo version 10 for data management and thematic coding. Coders identified major themes and subthemes that emerged from the interviews. RESULTS: Sixty women (n = 60) completed the interviews. The kappa among coders was 0.94. The mean age of participants was 43.0 ± 6.8. 61.7% of participants self-identified as African American, 25.0% as Caucasian, 8.3% as Hispanic, and 5.0% as Asian. Many women reported obtaining a delayed diagnosis for their uterine fibroids despite experiencing severe symptoms. There were five subthemes that identified why women delayed seeking treatment, which included the perception that their symptoms were "normal," they had a low knowledge of fibroids, they did not perceive themselves to be at risk for fibroids, they engaged in avoidance-based coping strategies, and/or they dissociated themselves from their fibroids. CONCLUSIONS: Many women with symptomatic fibroids live with this condition chronically without seeking care. It appears that for some, limited knowledge regarding fibroids and normal menstruation may lead to a distorted view of what is normal with regard to uterine bleeding, resulting in limited treatment seeking behavior. Others know their symptoms are abnormal but simply avoid the problem. There is a need for patient-centered and community-based education to improve women's knowledge of fibroids and symptoms and to promote treatment options.
BACKGROUND: Uterine fibroids are benign tumors that are the leading cause of hysterectomy in the United States. Despite their high prevalence and associated morbidity, there are little qualitative data characterizing what drives women's treatment-seeking behavior for their fibroids. METHODS:Women with symptomatic or recently treated uterine fibroids completed in-depth interviews and demographic surveys. Interviews were transcribed verbatim and uploaded to NVivo version 10 for data management and thematic coding. Coders identified major themes and subthemes that emerged from the interviews. RESULTS: Sixty women (n = 60) completed the interviews. The kappa among coders was 0.94. The mean age of participants was 43.0 ± 6.8. 61.7% of participants self-identified as African American, 25.0% as Caucasian, 8.3% as Hispanic, and 5.0% as Asian. Many women reported obtaining a delayed diagnosis for their uterine fibroids despite experiencing severe symptoms. There were five subthemes that identified why women delayed seeking treatment, which included the perception that their symptoms were "normal," they had a low knowledge of fibroids, they did not perceive themselves to be at risk for fibroids, they engaged in avoidance-based coping strategies, and/or they dissociated themselves from their fibroids. CONCLUSIONS: Many women with symptomatic fibroids live with this condition chronically without seeking care. It appears that for some, limited knowledge regarding fibroids and normal menstruation may lead to a distorted view of what is normal with regard to uterine bleeding, resulting in limited treatment seeking behavior. Others know their symptoms are abnormal but simply avoid the problem. There is a need for patient-centered and community-based education to improve women's knowledge of fibroids and symptoms and to promote treatment options.
Authors: Anca D Dragomir; Jane C Schroeder; AnnaMarie Connolly; Larry L Kupper; Michael C Hill; Andrew F Olshan; Donna D Baird Journal: Reprod Sci Date: 2010-08-06 Impact factor: 3.060
Authors: Geraldine E Ekpo; Marissa S Ghant; Liana M Woodley; Hannah S Recht; Tacoma McKnight; Erica E Marsh Journal: J Reprod Med Date: 2014 Sep-Oct Impact factor: 0.142
Authors: Erica E Marsh; Geraldine E Ekpo; Eden R Cardozo; Maureen Brocks; Tanaka Dune; Leeber S Cohen Journal: Fertil Steril Date: 2013-03-15 Impact factor: 7.329
Authors: Lauren A Wise; Julie R Palmer; Bernard L Harlow; Donna Spiegelman; Elizabeth A Stewart; Lucile L Adams-Campbell; Lynn Rosenberg Journal: Am J Epidemiol Date: 2004-01-15 Impact factor: 4.897
Authors: Leif I Solberg; Stephen E Asche; Louise H Anderson; Karen Sepucha; N Marcus Thygeson; Joan E Madden; Larry Morrissey; Karen K Kraemer Journal: J Womens Health (Larchmt) Date: 2009-07 Impact factor: 2.681
Authors: Luiz Gustavo Oliveira Brito; Marislei Sanches Panobianco; Maurício Mesquita Sabino-de-Freitas; Hermes de Freitas Barbosa; George Dantas de Azevedo; Luciane Maria Oliveira Brito; Francisco José Candido-Dos-Reis Journal: Reprod Health Date: 2014-01-30 Impact factor: 3.223
Authors: Erica E Marsh; Ayman Al-Hendy; Dale Kappus; Alex Galitsky; Elizabeth A Stewart; Majid Kerolous Journal: J Womens Health (Larchmt) Date: 2018-09-19 Impact factor: 2.681
Authors: Ijeoma Okeigwe; Serdar Bulun; Shimeng Liu; Alfred W Rademaker; John S Coon; Stacy Kujawa; Jared Robins; Ping Yin Journal: J Clin Endocrinol Metab Date: 2019-12-01 Impact factor: 5.958
Authors: Sarah R Hoffman; Leslie V Farland; Kemi M Doll; Wanda K Nicholson; Maya A Wright; Whitney R Robinson Journal: J Epidemiol Community Health Date: 2020-10-27 Impact factor: 3.710